264 related articles for article (PubMed ID: 21241714)
1. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome.
Luo ZF; Qi W; Feng B; Mu J; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Life Sci; 2011 Mar; 88(11-12):512-20. PubMed ID: 21241714
[TBL] [Abstract][Full Text] [Related]
2. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
Luo ZF; Feng B; Mu J; Qi W; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):49-57. PubMed ID: 20399799
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Streptozotocin-Induced Diabetic Nephropathy by MG132: Possible Roles of Nrf2 and I
Kong L; Wang Y; Luo M; Tan Y; Cui W; Miao L
Oxid Med Cell Longev; 2017; 2017():3671751. PubMed ID: 28373900
[TBL] [Abstract][Full Text] [Related]
4. MG132 ameliorates kidney lesions by inhibiting the degradation of Smad7 in streptozotocin-induced diabetic nephropathy.
Gao C; Aqie K; Zhu J; Chen G; Xu L; Jiang L; Xu Y
J Diabetes Res; 2014; 2014():918396. PubMed ID: 24511554
[TBL] [Abstract][Full Text] [Related]
5. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
6. MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy.
Zeng W; Qi W; Mu J; Wei Y; Yang LL; Zhang Q; Wu Q; Tang JY; Feng B
Sci Rep; 2019 Feb; 9(1):2049. PubMed ID: 30765727
[TBL] [Abstract][Full Text] [Related]
7. Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice.
Cui W; Li B; Bai Y; Miao X; Chen Q; Sun W; Tan Y; Luo P; Zhang C; Zheng S; Epstein PN; Miao L; Cai L
Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E87-99. PubMed ID: 23132297
[TBL] [Abstract][Full Text] [Related]
8. Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats.
Abou-Hany HO; Atef H; Said E; Elkashef HA; Salem HA
Chem Biol Interact; 2018 Mar; 284():90-100. PubMed ID: 29409856
[TBL] [Abstract][Full Text] [Related]
9. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
10. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection.
Dreger H; Westphal K; Weller A; Baumann G; Stangl V; Meiners S; Stangl K
Cardiovasc Res; 2009 Jul; 83(2):354-61. PubMed ID: 19351736
[TBL] [Abstract][Full Text] [Related]
11. Ferulsinaic acid attenuation of diabetic nephropathy.
Sayed AA
Eur J Clin Invest; 2013 Jan; 43(1):56-63. PubMed ID: 23190272
[TBL] [Abstract][Full Text] [Related]
12. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
13. Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity.
Xue W; Lei J; Li X; Zhang R
Nutr Res; 2011 Jul; 31(7):555-62. PubMed ID: 21840472
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats.
Shukla R; Banerjee S; Tripathi YB
BMC Complement Altern Med; 2018 May; 18(1):156. PubMed ID: 29751837
[TBL] [Abstract][Full Text] [Related]
15. [Effects of quercetin on nuclear factor-κB p65 expression in renal ubiquitin-proteasome system of diabetic rats].
Chen P; Chen JB; Chen WY; Zheng QL; Wang YQ; Xu XJ
Zhonghua Nei Ke Za Zhi; 2012 Jun; 51(6):460-5. PubMed ID: 22943758
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
[TBL] [Abstract][Full Text] [Related]
18. Effects of proteasome inhibitor, MG132, on proteasome activity and oxidative status of rat liver.
Alexandrova A; Petrov L; Georgieva A; Kirkova M; Kukan M
Cell Biochem Funct; 2008 Apr; 26(3):392-8. PubMed ID: 18236383
[TBL] [Abstract][Full Text] [Related]
19. Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.
An ZM; Dong XG; Guo Y; Zhou JL; Qin T
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):356-361. PubMed ID: 26072073
[TBL] [Abstract][Full Text] [Related]
20. Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.
Zou C; Liu X; Liu R; Wang M; Sui M; Mu S; Li L; Ji L; Xie R
J Diabetes; 2017 Apr; 9(4):332-340. PubMed ID: 27121697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
